<code id='7AD5463231'></code><style id='7AD5463231'></style>
    • <acronym id='7AD5463231'></acronym>
      <center id='7AD5463231'><center id='7AD5463231'><tfoot id='7AD5463231'></tfoot></center><abbr id='7AD5463231'><dir id='7AD5463231'><tfoot id='7AD5463231'></tfoot><noframes id='7AD5463231'>

    • <optgroup id='7AD5463231'><strike id='7AD5463231'><sup id='7AD5463231'></sup></strike><code id='7AD5463231'></code></optgroup>
        1. <b id='7AD5463231'><label id='7AD5463231'><select id='7AD5463231'><dt id='7AD5463231'><span id='7AD5463231'></span></dt></select></label></b><u id='7AD5463231'></u>
          <i id='7AD5463231'><strike id='7AD5463231'><tt id='7AD5463231'><pre id='7AD5463231'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:68559
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Finland to offer bird flu vaccine to select groups of people, a possible global first
          Finland to offer bird flu vaccine to select groups of people, a possible global first

          H5N1birdfluparticlesCDCandNIAIDLONDON—Finlandispreparingtooffervaccinestopeopleatriskofexposuretoana

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          Bernie Sanders gets little from pharma CEOs on drug prices

          Sen.BernieSanders(I-Vt.)raiseshishandataThursdayhearingonCapitolHillinWashingtontoexaminethecostofpr